Literature DB >> 19840131

What, if anything, is specific about having a rare disorder? Patients' judgements on being ill and being rare.

Caroline Huyard1.   

Abstract

BACKGROUND: Growing efforts are made to improve the situation of persons with rare diseases, but the specific nature of these disorders remains unclear.
OBJECTIVES: To establish (1) to what extent people with rare disorders think that their disease's rarity causes particular difficulties, (2) to what extent these difficulties relate to other causes than rarity (i.e. other characteristics of the disease or other components of the illness experience), (3) to what extent the rarity of the disease may relate to components of patients' experience other than those that are traditionally addressed (i.e. personal or daily life aspects).
METHODS: Semi-structured interviews with 29 patients and 15 parents of children with one of six rare diseases (cystic fibrosis, fragile X syndrome, Wilson's disease, mastocytosis, locked-in syndrome and a sixth syndrome). The interviews were conducted in France. The analysis draws on French pragmatic sociology and focuses on the participants' judgements of their experience. Findings The participants considered as normal and acceptable a range of situations that are often viewed as specific to rare disorders and unfair. This rather positive evaluation was conditional on some specific moral criteria being met. The participants attributed the cause of their difficulties to the failure of health professionals to meet these criteria. In the participants' experience, disease-related associations play a key role and rarity seems to contribute to making them especially important.
CONCLUSIONS: Patients' experience would be considerably improved if health professionals more often fulfilled their moral expectations, especially regarding diagnosis disclosure and information. (250 words).

Entities:  

Mesh:

Year:  2009        PMID: 19840131      PMCID: PMC5060508          DOI: 10.1111/j.1369-7625.2009.00552.x

Source DB:  PubMed          Journal:  Health Expect        ISSN: 1369-6513            Impact factor:   3.377


  10 in total

1.  [Rare diseases: a long ignored public health problem].

Authors:  S Aymé
Journal:  Rev Epidemiol Sante Publique       Date:  2001-09       Impact factor: 1.019

Review 2.  Orphan drugs and the NHS: should we value rarity?

Authors:  Christopher McCabe; Karl Claxton; Aki Tsuchiya
Journal:  BMJ       Date:  2005-10-29

Review 3.  [Epidemiologic challenges in rare diseases].

Authors:  S Rückinger; A Boneberger
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2008-05       Impact factor: 1.513

Review 4.  Naming and framing: the social construction of diagnosis and illness.

Authors:  P Brown
Journal:  J Health Soc Behav       Date:  1995

Review 5.  Rare diseases, drug development, and AIDS: the impact of the Orphan Drug Act.

Authors:  P S Arno; K Bonuck; M Davis
Journal:  Milbank Q       Date:  1995       Impact factor: 4.911

Review 6.  A journey of hope: lessons learned from studies on rare diseases and orphan drugs.

Authors:  M Wästfelt; B Fadeel; J-I Henter
Journal:  J Intern Med       Date:  2006-07       Impact factor: 8.989

7.  [Diagnostic management of patients with rare genetic diseases: example of five pathologies].

Authors:  V Godet; I Hirtzlin; N Costet
Journal:  Rev Epidemiol Sante Publique       Date:  2001-09       Impact factor: 1.019

Review 8.  Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?

Authors:  M L Schilsky
Journal:  Curr Gastroenterol Rep       Date:  2001-02

Review 9.  Life with a rare chronic disease: the scleroderma experience.

Authors:  Gloria Joachim; Sonia Acorn
Journal:  J Adv Nurs       Date:  2003-06       Impact factor: 3.187

10.  The role of an online community for people with a rare disease: content analysis of messages posted on a primary biliary cirrhosis mailinglist.

Authors:  Judith N Lasker; Ellen D Sogolow; Rebecca R Sharim
Journal:  J Med Internet Res       Date:  2005-03-31       Impact factor: 5.428

  10 in total
  17 in total

1.  Expectations, hopes and moral norms.

Authors:  Vikki A Entwistle
Journal:  Health Expect       Date:  2009-12       Impact factor: 3.377

2.  Reasons for attending support groups and organizational preferences: A replication study using the North American Scleroderma Support Group Survey.

Authors:  Mia Pépin; Linda Kwakkenbos; Marie-Eve Carrier; Sandra Peláez; Ghassan El-Baalbaki; Vanessa L Malcarne; Brett D Thombs
Journal:  J Scleroderma Relat Disord       Date:  2019-05-29

3.  Randomized feasibility trial of the Scleroderma Patient-centered Intervention Network hand exercise program (SPIN-HAND): Study protocol.

Authors:  Marie-Eve Carrier; Linda Kwakkenbos; Isabelle Boutron; Joep Welling; Maureen Sauve; Cornelia van den Ende; Anne A Schouffoer; Marie Hudson; Brett D Thombs; Luc Mouthon
Journal:  J Scleroderma Relat Disord       Date:  2017-10-16

4.  The "technoscientization" of medicine and its limits: technoscientific identities, biosocialities, and rare disease patient organizations.

Authors:  Peter Wehling
Journal:  Poiesis Prax       Date:  2011-11-10

5.  Illness Perception, Perceived Social Support and Quality of Life in Patients with Pemphigus Vulgaris: What Should Dermatologists Know?

Authors:  Oz Segal; Gil Goldzweig; Einat Tako; Aviv Barzilai; Anna Lyakhovitsky; Sharon Baum
Journal:  Acta Derm Venereol       Date:  2021-04-27       Impact factor: 3.875

6.  Assisting a child with tuberous sclerosis complex (TSC): a qualitative deep analysis of parents' experience and caring needs.

Authors:  Guendalina Graffigna; Caterina Bosio; Isabella Cecchini
Journal:  BMJ Open       Date:  2013-12-06       Impact factor: 2.692

Review 7.  Living with a rare disorder: a systematic review of the qualitative literature.

Authors:  Charlotte von der Lippe; Plata S Diesen; Kristin B Feragen
Journal:  Mol Genet Genomic Med       Date:  2017-07-23       Impact factor: 2.183

8.  Identifying the unmet health needs of patients with congenital hypogonadotropic hypogonadism using a web-based needs assessment: implications for online interventions and peer-to-peer support.

Authors:  Andrew A Dwyer; Richard Quinton; Diane Morin; Nelly Pitteloud
Journal:  Orphanet J Rare Dis       Date:  2014-06-11       Impact factor: 4.123

9.  Health-related quality of life among adults with diverse rare disorders.

Authors:  Kathleen R Bogart; Veronica L Irvin
Journal:  Orphanet J Rare Dis       Date:  2017-12-07       Impact factor: 4.123

10.  Quality of life in adults with lymphedema cholestasis syndrome 1.

Authors:  Kristin Iversen; Lill Monica Drivdal; Kristin J Billaud Feragen; Amy Østertun Geirdal
Journal:  Health Qual Life Outcomes       Date:  2018-07-25       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.